Minerva Neurosciences, Inc. announced that it has entered into a securities purchase agreement to issue an aggregate of 1,425,000 shares at a price of $10 per share for the gross proceeds of $14.25 million and 575,575 pre-funded warrants at a price of $9.99 per warrant for the gross proceeds of $5.749994 million for the total gross proceeds of $19.999994 million on June 27, 2023. Each warrant has an exercise price of 0.01 per warrant. The transaction is expected to close on or about June 30, 2023.